| 产品详情 |
| Edit |   |
|---|
| Product Name | CA-125 ELISA Kit |
|---|
| Description | Samples: Human serumSensitivity: Healthy women are expected to have CA125 assay values below 35 U/ml. The minimum detectable concentration of CA125 in this assay is estimated to be 5 U/ml. |
|---|
| Size | 96-strip-wells |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | CA-125 |
|---|
| Catalog # | MBS580046 |
|---|
| Price | |
|---|
| Order / More Info | CA-125 ELISA Kit from MYBIOSOURCE INC. |
|---|
| Product Specific References | 1. all, E., Methods in Enzymology, Volume 70, Van Vunakis, H. and Langone, J. J. (eds.), Academic Press, New York, 419- 492 (1980). 1. tila, M., Ruoslahti, E. and Engvall, E., J. lmmunol. Methods, 42, 11-15 (1981). 2. Kenemans P, Yedema CA, Bon GG, von Mensdorff-Pouilly S. Ca125 in gynecological pathology a review. Eur J Obstet Gynecol 1993;49:115-124. 3. Saksela F. Prognostic markers in epithelial ovarian cancer. Intl J Gynecol Pathol 1993;12:156-161. 4. Farghaly SA. Tumor markers in gynecologic cancer. Gynecol & Obstet Invest 1992;34:65- 72. 5. Welander CE. What do CA 125 and other antigens tell us about ovarian cancer biology. Acta Obstet Gynecol Scand Sup 1992;155:85-93. 6. McGowan L. Pathology of the ovary. Curr Opin on Obstet Gynecol 1991;3:580-586. 7. Niloff JM. Ovarian malignancy. Curr Opin on Obstet Gynecol 1991;3:66-72. 8. Olt G, Berchuck A, Bast RC. The role of tumor markers in gynecologic oncology. Obstet Gynecol Survey 1990;45-:570-577. 9. Diez M, Cerdan FJ, Ortega MD, Torres A, Picardo A, Balibrea JL. Evaluation of serum CA125 as a tumor marker in non-small cell lung cancer. Cancer 1991;67:150-154. 10. Niloff JM, Klug TL, Schaetzl E. Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix. AM J. Obstet Gynecol 1984; 148:1057 |
|---|
| 产品资料 |
|
|